The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ilyukhin E.A.

Surgical clinic Medalp

Kurginyan Kh.M.

Laser surgery clinic “Varicose No”

Kovalenko K.E.

Laser surgery clinic “Varicose No”

Norvardyan A.M.

Laser surgery clinic “Varicose No”

Abukhamdan A.S.

Laser surgery clinic “Varicose No”

Gevorgyan A.A.

Laser surgery clinic “Varicose No”

Kartoev I.R.

Laser surgery clinic “Varicose No”

Impact of Micronized Purified Flavonoid Fraction on Subjective Symptoms After Endovenous Laser Varicose Vein Surgery: the Protocol of the Randomized Controlled Trial DEMO

Authors:

Ilyukhin E.A., Kurginyan Kh.M., Kovalenko K.E., Norvardyan A.M., Abukhamdan A.S., Gevorgyan A.A., Kartoev I.R.

More about the authors

Journal: Journal of Venous Disorders. 2023;17(4): 338‑342

Read: 1337 times


To cite this article:

Ilyukhin EA, Kurginyan KhM, Kovalenko KE, Norvardyan AM, Abukhamdan AS, Gevorgyan AA, Kartoev IR. Impact of Micronized Purified Flavonoid Fraction on Subjective Symptoms After Endovenous Laser Varicose Vein Surgery: the Protocol of the Randomized Controlled Trial DEMO. Journal of Venous Disorders. 2023;17(4):338‑342. (In Russ.)
https://doi.org/10.17116/flebo202317041338

Recommended articles:

References:

  1. Perrin M, Eklof B, VAN Rij A, Labropoulos N, Vasquez M, Nicolaides A, Blattler W, Bouhassira D, Bouskela E, Carpentier P, Darvall K, De Maeseneer M, Flour M, Guex JJ, Hamel-Desnos C, Kakkos S, Launois R, Lugli M, Maleti O, Mansilha A, NEGLéN P, Rabe E, Shaydakov E. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. Int Angiol. 2016;35(4):374-398. 
  2. Zolotukhin IA, Seliverstov EI, Shevtsov YuN, Avakiants IP, Nikishkov AI, Tatarintsev AM, Kirienko AI. Prevalence of Chronic Venous Disease: Results of Population Based Epidemiological Study. Flebologiya. 2016;10(3):119-125. (In Russ.). https://doi.org/10.17116/flebo2016103119-125
  3. Zolotukhin IA, Seliverstov EI, Shevtsov YN, Avakiants IP, Tatarintsev AM, Kirienko AI, Zolotukhin IA, Seliverstov EI, Shevtsov YN, Avakiants IP. Risk factors for venous symptoms in Russian patients with chronic venous disease Risk factors for venous symptoms in Russian patients with chronic. Curr Med Res Opin Taylor & Francis. 2019;35(9):1583-1587.
  4. Klitfod L, Sillesen H, Jensen LP. Patients and physicians agree only partially in symptoms and clinical findings before and after treatment for varicose veins. Phlebology. 2018;33(2):115-121. 
  5. Kakkos SK, Nicolaides AN. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: A systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Int Angiol Italy. 2018;37(2):143-154. 
  6. Bush R, Comerota A, Meissner M, Raffetto JD, Hahn SR, Freeman K. Recommendations for the medical management of chronic venous disease: The role of Micronized Purified Flavanoid Fraction (MPFF). Phlebology. 2017;32(1 Suppl):3-19. 
  7. Lobastov KV. Impact of Microcirculatory Disorders on the Symptoms of Chronic Venous Disease and Their Pharmacological Correction. Flebologiya. 2020;14(1):30-39. (In Russ.). https://doi.org/10.17116/flebo20201401130
  8. Instructions for the medical use of the drug Detravenol. [Electronic resource]. 2023. (In Russ.). Accessed October 08, 2023. https://grls.minzdrav.gov.ru/Grls_View_v2.aspx?routingGuid=caf9ce72-2936-427d-bfff-7387f09f5f81
  9. The Russian Phlebological Association. Varicose veins of the lower extremities [Electronic resource]. 2021. (In Russ.). Accessed October 08, 2023. https://cr.minzdrav.gov.ru/recomend/680_1
  10. De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, Giannoukas A, Gohel M, de Graaf R, Hamel-Desnos C, Jawien A, Jaworucka-Kaczorowska A, Lattimer CR, Mosti G, Noppeney T, van Rijn MJ, Stansby G, Esvs Guidelines Committee, Kolh P, Bastos Goncalves F, Chakfé N, Coscas R, de Borst GJ, Dias NV, Hinchliffe RJ, Koncar IB, Lindholt JS, Trimarchi S, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, Björck M, Labropoulos N, Lurie F, Mansilha A, Nyamekye IK, Ramirez Ortega M, Ulloa JH, Urbanek T, van Rij AM, Vuylsteke ME. Editor’s Choice ‒ European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg. 2022;63(2):184-267. 
  11. Kamaev AA, Bulatov VL, Vakhratyan PE, Volkov AM, Volkov AS, Gavrilov EK, Golovina VI, Efremova OI, Ivanov OO, Ilyukhin EA, Katorkin SE, Konchugova TV, Kravtsov PF, Maksimov SV, Mzhavanadze ND, Pikhanova ZhM, Pryadko SI, Smirnov AA, Sushkov SA, Chabbarov RG, Shimanko AI, Yakushkin SN, Aphanova TV, Derkachev SN, Zolotukhin IA, Kalinin RE, Kirienko AI, Kulchitskaya DB, Pelevin AV, Petrikov AS, Rachin AP, Seliverstov EI, Stoyko YuM, Suchkov IA. Varicose Veins. Recommendations of the Association of Phlebologists of Russia. Flebologiya. 2022;16(1):41-108. (In Russ.). https://doi.org/10.17116/flebo20221601141
  12. Russian Registry of Treatment of Chronic Venous Disease (RRT CVD). DEMO: RCT MOFF Detravenol in the postoperative period [Electronic resource]. 2023. (In Russ.). Accessed November 09, 2023. https://www.venousregistry.org/index.php?f=1&id=108

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.